Cargando…
Localisation of lung cancer by a radiolabelled monoclonal antibody against the c-myc oncogene product.
A set of mouse nonoclonal antibodies against the c-myc oncogene product, a 62,000 dalton nuclear binding protein involved in cell cycle control, has been constructed by immunisation with synthetic peptide fragments. One such antibody, CT14, was radiolabelled with 131I and administered to 20 patients...
Autores principales: | Chan, S. Y., Evan, G. I., Ritson, A., Watson, J., Wraight, P., Sikora, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001543/ https://www.ncbi.nlm.nih.gov/pubmed/3801273 |
Ejemplares similares
-
Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.
por: Smedley, H. M., et al.
Publicado: (1983) -
Detection of the c-myc oncogene product in testicular cancer.
por: Sikora, K., et al.
Publicado: (1985) -
Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
por: Bruland, O., et al.
Publicado: (1987) -
Detection of the c-myc oncogene product in colonic polyps and carcinomas.
por: Stewart, J., et al.
Publicado: (1986) -
Radiolabelled monoclonal antibodies in the treatment of metastatic cancer
por: Goldenberg, D.M.
Publicado: (2007)